Seike M - Search Results

1

A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630.

Taniguchi Y, Shimokawa T, Takiguchi Y, Misumi T, Nakamura Y, Kawashima Y, Furuya N, Shiraishi Y, Harada T, Tanaka H, Miura S, Uchiyama A, Nakahara Y, Tokito T, Naoki K, Bessho A, Goto Y, Seike M, Okamoto H. Taniguchi Y, et al. Among authors: seike m. Clin Cancer Res. 2022 Oct 14;28(20):4402-4409. doi: 10.1158/1078-0432.CCR-22-1687. Clin Cancer Res. 2022. PMID: 35980349 Free PMC article. Clinical Trial.

2

Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53.

Seike M, Gemma A, Hosoya Y, Hemmi S, Taniguchi Y, Fukuda Y, Yamanaka N, Kudoh S. Seike M, et al. Clin Cancer Res. 2000 Nov;6(11):4307-13. Clin Cancer Res. 2000. PMID: 11106248

3

Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer.

Ando M, Kobayashi K, Yoshimura A, Kurimoto F, Seike M, Nara M, Moriyama G, Mizutani H, Hibino S, Gemma A, Okano T, Shibuya M, Kudoh S. Ando M, et al. Among authors: seike m. Lung Cancer. 2004 Apr;44(1):121-7. doi: 10.1016/j.lungcan.2003.10.003. Lung Cancer. 2004. PMID: 15013590 Clinical Trial.

4

Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA).

Kokubo Y, Gemma A, Noro R, Seike M, Kataoka K, Matsuda K, Okano T, Minegishi Y, Yoshimura A, Shibuya M, Kudoh S. Kokubo Y, et al. Among authors: seike m. Br J Cancer. 2005 May 9;92(9):1711-9. doi: 10.1038/sj.bjc.6602559. Br J Cancer. 2005. PMID: 15870831 Free PMC article.

5

Phase I/II study of paclitaxel + carboplatin for refractory or recurrent non-small cell lung cancer.

Gemma A, Seike M, Kosaihira S, Minegishi Y, Noro R, Nara M, Hosomi Y, Okano T, Kokubo Y, Yoshimura A, Shibuya M, Kudoh S. Gemma A, et al. Among authors: seike m. Anticancer Res. 2006 Jul-Aug;26(4B):3083-7. Anticancer Res. 2006. PMID: 16886638 Free article. Clinical Trial.

6

Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation.

Noro R, Gemma A, Kosaihira S, Kokubo Y, Chen M, Seike M, Kataoka K, Matsuda K, Okano T, Minegishi Y, Yoshimura A, Kudoh S. Noro R, et al. Among authors: seike m. BMC Cancer. 2006 Dec 6;6:277. doi: 10.1186/1471-2407-6-277. BMC Cancer. 2006. PMID: 17150102 Free PMC article.

7

Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model.

Miyanaga A, Gemma A, Noro R, Kataoka K, Matsuda K, Nara M, Okano T, Seike M, Yoshimura A, Kawakami A, Uesaka H, Nakae H, Kudoh S. Miyanaga A, et al. Among authors: seike m. Mol Cancer Ther. 2008 Jul;7(7):1923-30. doi: 10.1158/1535-7163.MCT-07-2140. Epub 2008 Jul 7. Mol Cancer Ther. 2008. PMID: 18606719

8

The anticancer effect of histone deacetylase inhibitors and combination with the cytotoxic agents in lung cancer cells: biological analyses for future clinical application.

Noro R, Miyanaga A, Shimokawa T, Kuribayashi H, Mizutani H, Minegishi Y, Okano T, Seike M, Soeno C, Kataoka K, Matsuda K, Yoshimura A, Gemma A. Noro R, et al. Among authors: seike m. J Nippon Med Sch. 2009 Feb;76(1):44-6. doi: 10.1272/jnms.76.44. J Nippon Med Sch. 2009. PMID: 19305113 Free article. No abstract available.

9

Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expression.

Noro R, Miyanaga A, Minegishi Y, Okano T, Seike M, Soeno C, Kataoka K, Matsuda K, Yoshimura A, Gemma A. Noro R, et al. Among authors: seike m. Cancer Sci. 2010 Jun;101(6):1424-30. doi: 10.1111/j.1349-7006.2010.01559.x. Epub 2010 Mar 10. Cancer Sci. 2010. PMID: 20384633 Free article.

10

The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias.

Minegishi Y, Sudoh J, Kuribayasi H, Mizutani H, Seike M, Azuma A, Yoshimura A, Kudoh S, Gemma A. Minegishi Y, et al. Among authors: seike m. Lung Cancer. 2011 Jan;71(1):70-4. doi: 10.1016/j.lungcan.2010.04.014. Epub 2010 May 20. Lung Cancer. 2011. PMID: 20493578 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

343 results

Search Page